This edition contains articles on:
> D’Arcy v Myriad Genetics Inc.
> Considerations when developing a foreign trade mark filing strategy
> High Court clarifies the test for inventive step over prior art in AstraZeneca AB v Apotex
> Will breakthroughs in genetic technology make genetic engineered crops more palatable?
> IP protection for digital health apps in Australia
> and more